Details
Stereochemistry | ACHIRAL |
Molecular Formula | C22H29N2O.Br |
Molecular Weight | 417.382 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Br-].C[N+]3(CCC(C(N)=O)(C1=CC=CC=C1)C2=CC=CC=C2)CCCCC3
InChI
InChIKey=PMAHPMMCPXYARU-UHFFFAOYSA-N
InChI=1S/C22H28N2O.BrH/c1-24(16-9-4-10-17-24)18-15-22(21(23)25,19-11-5-2-6-12-19)20-13-7-3-8-14-20;/h2-3,5-8,11-14H,4,9-10,15-18H2,1H3,(H-,23,25);1H
Molecular Formula | BrH |
Molecular Weight | 80.912 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C22H29N2O |
Molecular Weight | 337.4785 |
Charge | 1 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Fenpiverinium is a quaternary ammonium compound, it is an anticholinergic and antispasmodic agent. It is a constituent of Baralgin. The effects of the constituents of Baralgin (metamizole , fenpiverinium, and pitofenone ) on mechanical activity were studied in isolated human preparations of the upper urinary tract. Fenpiverinium blocked the increase in frequency of phasic-rhythmic contractions and the tonic tension development induced by acetylcholine. Fenpiverinium did influence neither spontaneous phasic activity nor activation by high potassium or norepinephrine. Fenpiverinium has exclusively anticholinergic properties. Fenpiverinium is a muscarinic acetylcholine receptor antagonist.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094109 Sources: https://www.genome.jp/dbget-bin/www_bget?dr:D07070 |
PubMed
Title | Date | PubMed |
---|---|---|
[Effect of Baralgin on isolated preparations of the upper urinary tract in man]. | 1984 |
|
Analgesics for pain relief after gynaecological surgery. A two-phase study. | 1985 Mar 2 |
|
Open labelled evaluation of injection Manyana (a combination of diclofenac + pitofenone + fenpiverinium) in ureteric, biliary and intestinal spasm--a preliminary report. | 1999 Sep |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3885441
A two-phase, double-blind study was performed to assess the efficacy of various drugs in the relief of postoperative pain. Oral analgesia with two compounds (paracetamol 320 mg, caffeine 32 mg, codeine phosphate 8 mg and meprobamate 150 mg (Stopayne; Rio Ethicals) and dipyrone 500 mg, pitofenone hydrochloride 5 mg and fenpiverinium bromide 0,1 mg (Baralgan HS; Albert)) was found to produce satisfactory pain relief, and it is suggested that these oral compounds may be used from 12 hours postoperatively in uncomplicated cases.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:28:31 GMT 2023
by
admin
on
Fri Dec 15 16:28:31 GMT 2023
|
Record UNII |
36479UA8GL
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29704
Created by
admin on Fri Dec 15 16:28:31 GMT 2023 , Edited by admin on Fri Dec 15 16:28:31 GMT 2023
|
||
|
NCI_THESAURUS |
C29698
Created by
admin on Fri Dec 15 16:28:31 GMT 2023 , Edited by admin on Fri Dec 15 16:28:31 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID0046484
Created by
admin on Fri Dec 15 16:28:31 GMT 2023 , Edited by admin on Fri Dec 15 16:28:31 GMT 2023
|
PRIMARY | |||
|
m1161
Created by
admin on Fri Dec 15 16:28:31 GMT 2023 , Edited by admin on Fri Dec 15 16:28:31 GMT 2023
|
PRIMARY | Merck Index | ||
|
71489
Created by
admin on Fri Dec 15 16:28:31 GMT 2023 , Edited by admin on Fri Dec 15 16:28:31 GMT 2023
|
PRIMARY | |||
|
SUB07590MIG
Created by
admin on Fri Dec 15 16:28:31 GMT 2023 , Edited by admin on Fri Dec 15 16:28:31 GMT 2023
|
PRIMARY | |||
|
3050
Created by
admin on Fri Dec 15 16:28:31 GMT 2023 , Edited by admin on Fri Dec 15 16:28:31 GMT 2023
|
PRIMARY | |||
|
C005711
Created by
admin on Fri Dec 15 16:28:31 GMT 2023 , Edited by admin on Fri Dec 15 16:28:31 GMT 2023
|
PRIMARY | |||
|
204-744-9
Created by
admin on Fri Dec 15 16:28:31 GMT 2023 , Edited by admin on Fri Dec 15 16:28:31 GMT 2023
|
PRIMARY | |||
|
SUB90945
Created by
admin on Fri Dec 15 16:28:31 GMT 2023 , Edited by admin on Fri Dec 15 16:28:31 GMT 2023
|
PRIMARY | |||
|
100000092337
Created by
admin on Fri Dec 15 16:28:31 GMT 2023 , Edited by admin on Fri Dec 15 16:28:31 GMT 2023
|
PRIMARY | |||
|
C65668
Created by
admin on Fri Dec 15 16:28:31 GMT 2023 , Edited by admin on Fri Dec 15 16:28:31 GMT 2023
|
PRIMARY | |||
|
36479UA8GL
Created by
admin on Fri Dec 15 16:28:31 GMT 2023 , Edited by admin on Fri Dec 15 16:28:31 GMT 2023
|
PRIMARY | |||
|
125-60-0
Created by
admin on Fri Dec 15 16:28:31 GMT 2023 , Edited by admin on Fri Dec 15 16:28:31 GMT 2023
|
PRIMARY | |||
|
CHEMBL1884833
Created by
admin on Fri Dec 15 16:28:31 GMT 2023 , Edited by admin on Fri Dec 15 16:28:31 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |